Table 1.

[¹⁴C]-radioactivity in selected tissues and excreta following a single BEH-TEBP administration (72 h post dose).

	Dose recovered	0.1 μmol/kg (Mouse, oral)	0.1 μmol/kg (Rat, oral)	10 μmol/kg (Rat, oral)	0.1 μmol/kg (Rat, IV)
Feces	%	92 ± 7	98 ± 8	98 ± 1	77 ± 4
Urine	%	3 ± 2	0.3 ± 0.03	0.3 ± 0.04	1.3 ± 0.2
Adipose	%	0.1 ± 0.03	0.01 ± 0.01	0.03 ± 0.01	2 ± 0.4
	(pmol-eq/g)	(2 ± 1)	(0.04 ± 0.1)	(28 ± 10)	(15 ± 3)
Adrenal	%	0.01 ± 0.004	0.002 ± 0.002	0.004 ± 0.002	1 ± 0.1
	(pmol-eq/g)	(18 ± 6)	(7 ± 5)	(1314 ± 451)	(2207 ± 1246)
Blood	%	0.02 ± 0.01	0.4 ± 0.4	0.1 ± 0.1	1 ± 0.3
	(pmol-eq/g)	(0.02 ± 0.01)	(0.2 ± 0.2)	(3 ± 5)	(0.4 ± 0.1)
Brain	%	0.01 ± 0.01	0.0002 ± 0.0004	0.001 ± 0.001	0.04 ± 0.02
	(pmol-eq/g)	(1 ± 1)	(0.02 ± 0.05)	(13 ± 14)	(5 ± 2)
Kidney	%	0.01 ± 0.01	0.001 ± 0.001	0.002 ± 0.002	0.2 ± 0.03
	(pmol-eq/g)	(1 ± 1)	(0.1 ± 0.1)	(21 ± 32)	(22 ± 4)
Liver	%	0.3 ± 0.1	0.2 ± 0.2	0.4 ± 0.1	7 ± 1
	(pmol-eq/g)	(11 ± 0.4)	(4 ± 5)	(873 ± 328)	(144 ± 21)
Lung	%	0.01 ± 0.01	0.001 ± 0.001	0.002 ± 0.0004	0.1 ± 0.02
	(pmol-eq/g)	(2 ± 2)	(0.1 ± 0.2)	(29 ± 4)	(20 ± 5)
Muscle	%	0.1 ± 0.1	0.1 ± 0.2	0.1 ± 0.1	5 ± 1
	(pmol-eq/g)	(0.4 ± 0.3)	(0.2 ± 0.4)	(10 ± 14)	(10 ± 2)
Skin	%	0.001 ± 0.002	0.01 ± 0.01	0.04 ± 0.02	3 ± 0.4
	(pmol-eq/g)	(0.01 ± 0.02)	(0.04 ± 0.1)	(24 ± 13)	(17 ± 3)